1. RBM10 recruits METTL3 to induce N6-methyladenosine-MALAT1-dependent modification, inhibiting the invasion and migration of NSCLC
   Yingshu Cao et al, 2023, Life Sciences CrossRef
2. The mechanism of BUD13 m6A methylation mediated MBNL1-phosphorylation by CDK12 regulating the vasculogenic mimicry in glioblastoma cells
   Meichen Liu et al, 2022, Cell Death & Disease CrossRef
3. Pseudorabies virus exploits N6-methyladenosine modification to promote viral replication
   Pei-Lun Yu et al, 2023, Frontiers in Microbiology CrossRef
4. RNA m6A methylation regulators in liver cancer
   Qiaoping Xu et al, 2024, Cancer Cell International CrossRef
5. Role of N6‑methyladenosine in the pathogenesis, diagnosis and treatment of prostate cancer (Review)
   Junjie Pan et al, 2024, Oncology Reports CrossRef
6. Underexplored reciprocity between genome-wide methylation status and long non-coding RNA expression reflected in breast cancer research: potential impacts for the disease management in the framework of 3P medicine
   Andrea Kapinova et al, 2023, EPMA Journal CrossRef
7. BIRC5 facilitates cisplatin‐chemoresistance in a m6A‐dependent manner in ovarian cancer
   Yadan Fan et al, 2024, Cancer Medicine CrossRef
8. Decreased Expression of Programmed Death Ligand-L1 by Seven in Absentia Homolog 2 in Cholangiocarcinoma Enhances T-Cell–Mediated Antitumor Activity
   Hao Zheng et al, 2022, Frontiers in Immunology CrossRef
9. Curcumin: An epigenetic regulator and its application in cancer
   Tianqi Ming et al, 2022, Biomedicine & Pharmacotherapy CrossRef
10. METTL16 in human diseases: What should we do next?
    Hui Zhang et al, 2023, Open Medicine CrossRef